We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AmpTec

News List

Merck launches synthetic cholesterol product to meet high demand for lipids expresspharma
May 31, 2021
This neutral lipid, used in commercially marketed products, is more than 99 per cent pure; offers high batch-to-batch consistency and is scalable under commercial GMP.
MilliporeSigma Acquires AmpTec contractpharma
January 08, 2021
MilliporeSigma has announced the acquisition of AmpTec, a Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).
Merck acquires Germany-based CDMO, AmpTec expresspharma
January 08, 2021
The acquisition to expand Merck’s lipid manufacturing expertise and mRNA capabilities for vaccines, treatments and diagnostics.